Neoplasms

"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Descriptor ID	D009369
MeSH Number(s)	C04
Concept/Terms	Neoplasms Neoplasms Neoplasia Neoplasias Neoplasm Tumors Tumor Cancer Cancer Cancers Malignant Neoplasms Malignant Neoplasm Neoplasm, Malignant Neoplasms, Malignant Malignancy Malignancies Benign Neoplasms Benign Neoplasms Neoplasms, Benign Benign Neoplasm Neoplasm, Benign

Below are MeSH descriptors whose meaning is more general than "Neoplasms".

Diseases [C]
Neoplasms [C04]

Below are MeSH descriptors whose meaning is more specific than "Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.

Bar chart showing 1981 publications over 30 distinct years, with a maximum of 108 publications in 2021 and 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	9	5	14
1997	9	3	12
1998	12	4	16
1999	13	3	16
2000	12	4	16
2001	21	3	24
2002	34	9	43
2003	31	5	36
2004	32	12	44
2005	58	13	71
2006	48	18	66
2007	52	8	60
2008	56	15	71
2009	66	16	82
2010	61	16	77
2011	53	20	73
2012	64	13	77
2013	79	17	96
2014	79	13	92
2015	92	11	103
2016	90	11	101
2017	80	15	95
2018	83	7	90
2019	74	13	87
2020	102	4	106
2021	101	7	108
2022	87	2	89
2023	106	2	108
2024	70	27	97
2025	10	1	11

Below are the most recent publications written about "Neoplasms" by people in Profiles.

Maskalenko NA, Zahroun S, Tsygankova O, Anikeeva N, Sykulev Y, Campbell KS. The Fc?RIIIA (CD16) L48-H/R Polymorphism Enhances NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity by Promoting Serial Killing. Cancer Immunol Res. 2025 Mar 04; 13(3):417-429.

View in: PubMed
Perez Ramirez A, McDonnell GA, Buff K, Pierce J, Wohlheiter K, Guarino S, Kazak AE, Alderfer MA. Attending to Adolescents' Well-Being During Their Transition off Cancer Treatment: Perspectives from a Nationwide Crowdsourcing Study. J Adolesc Young Adult Oncol. 2025 Oct; 14(5):420-433.

View in: PubMed
Basch E, Schrag D, Jansen J, Henson S, Ginos B, Stover AM, Carr P, Spears PA, Jonsson M, Deal AM, Bennett AV, Thanarajasingam G, Rogak L, Reeve BB, Snyder C, Bruner D, Cella D, Kottschade LA, Perlmutter J, Geoghegan C, Given B, Mazza GL, Miller R, Strasser JF, Zylla DM, Weiss A, Blinder VS, Wolf AP, Dueck AC. Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial. Nat Med. 2025 Apr; 31(4):1225-1232.

View in: PubMed
Schilder RJ, Rasco D, Sharma MR. An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors. Neoplasia. 2025 03; 61:101133.

View in: PubMed
Davis KA, Lai S, Alderfer MA, Long KA. Shared Priorities for Sibling Psychosocial Support in Pediatric Cancer Care: A Value-Weighting Study. Pediatr Blood Cancer. 2025 Apr; 72(4):e31565.

View in: PubMed
Burus T, McAfee CR, Hull PC, Leader AE, McNair C. Tracking community outreach and engagement activities among National Cancer Institute-designated cancer centers. J Natl Cancer Inst. 2025 Feb 01; 117(2):335-337.

View in: PubMed
Castagnino PA, Haas DA, Musante L, Tancler NA, Tran BV, Kean R, Steck AR, Martinez LA, Mostaghel EA, Hooper DC, Kim FJ. Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles. Cancer Biol Ther. 2025 Dec; 26(1):2455722.

View in: PubMed
Lehrer EJ, Khunsriraksakul C, Garrett S, Trifiletti DM, Sheehan JP, Guckenberger M, Louie AV, Siva S, Ost P, Goodman KA, Dawson LA, Tchelebi LT, Yang JT, Showalter TN, Park HS, Spratt DE, Kishan AU, Gupta GP, Shah C, Fanti S, Calais J, Wang M, Schmitz K, Liu D, Abraham JA, Dess RT, Buvat I, Solomon B, Zaorsky NG. Future directions in the evaluation and management of newly diagnosed metastatic cancer. Crit Rev Oncol Hematol. 2025 Apr; 208:104631.

View in: PubMed
Alden SL, Charmsaz S, Li HL, Tsai HL, Danilova L, Munjal K, Brancati M, Warner A, Howe K, Griffin E, Nakazawa M, Thoburn C, Gizzi J, Hernandez A, Gross NE, Coyne EM, Hallab E, Shin SS, Durham J, Lipson EJ, Ged Y, Baretti M, Hoffman-Censits J, Seiwert TY, Guha A, Bansal S, Tang L, Chandler GS, Mohindra R, Garonce-Hediger R, Jaffee EM, Ho WJ, Kao C, Yarchoan M. Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade. J Immunother Cancer. 2025 Jan 19; 13(1).

View in: PubMed
Ali CR, Litvintchouk AM, Moeller P, Davis R, Hannan E, Maio V, Csik VP. Depression and Distress Screening in Oncology Patients: A Descriptive Analysis. Am J Med Qual. 2025 Jan-Feb 01; 40(1):1-7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement